Literature DB >> 20934436

Insulin resistance induced by a high-fat diet is associated with the induction of genes related to leukocyte activation in rat peripheral leukocytes.

Saki Fujimoto1, Kazuki Mochizuki, Masaya Shimada, Tomoyo Hori, Yuki Murayama, Norio Ohashi, Toshinao Goda.   

Abstract

AIMS: Insulin resistance caused by a high-fat diet induces type 2 diabetes and its complications. In this study, we investigated gene expression changes in peripheral leukocytes with insulin resistance by conducting microarray analyses in rats with high-fat diet-induced insulin resistance. MAIN
METHODS: After assessing insulin resistance in rats by an oral glucose tolerance test, we performed microarray analyses using peripheral leukocytes from normal rats and insulin-resistant rats after fasting. Real-time RT-PCR analyses were performed for several upregulated genes in the microarray data after fasting and at 3h after a single oral glucose load. KEY
FINDINGS: Feeding rats a high-fat diet for 77days induced moderate insulin resistance. Microarray analysis showed that the high-fat diet enhances many genes related to leukocyte activation. These upregulated genes included genes related to host defense, and many genes related to G-protein-coupled receptor/tyrosine receptor signaling. Moreover, many genes, such as Anxa1, S100a8, Il22ra2, Gng10, Csf3r and Cd302, showed further upregulation of their expression after a single oral glucose load. Exposure to high glucose and/or tumor necrosis factor-α which is known to be a factor that induces insulin resistance, enhanced the mRNA levels of DUSP1, ANXA1, IL1B, S100A8, IL22RA2, S100A9 and IRF1 in human monocyte-like U937 cells. SIGNIFICANCE: These results suggest that the expression of genes related to leukocyte activation in peripheral leukocytes is associated with the development of moderate insulin resistance.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20934436     DOI: 10.1016/j.lfs.2010.10.001

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Hypoglycemic effects of glycosaminoglycan from Urechis unicinctus in diabetic mice.

Authors:  Chunying Yuan; Ping Liu; Xu Han; Qingman Cui
Journal:  J Med Food       Date:  2014-10-07       Impact factor: 2.786

2.  Effects of chronic calorie restriction or dietary resveratrol supplementation on insulin sensitivity markers in a primate, Microcebus murinus.

Authors:  Julia Marchal; Stéphane Blanc; Jacques Epelbaum; Fabienne Aujard; Fabien Pifferi
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

3.  Increased adiposity in annexin A1-deficient mice.

Authors:  Rand T Akasheh; Maria Pini; Jingbo Pang; Giamila Fantuzzi
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

Review 4.  Biochemical and nutritional overview of diet-induced metabolic syndrome models in rats: what is the best choice?

Authors:  Eduardo Rodríguez-Correa; Imelda González-Pérez; Pedro Isauro Clavel-Pérez; Yolanda Contreras-Vargas; Karla Carvajal
Journal:  Nutr Diabetes       Date:  2020-07-02       Impact factor: 5.097

5.  Glucose and TNF enhance expression of TNF and IL1B, and histone H3 acetylation and K4/K36 methylation, in juvenile macrophage cells.

Authors:  Kazue Honma; Chie Machida; Kazuki Mochizuki; Toshinao Goda
Journal:  Gene X       Date:  2020-04-22

6.  Prednisolone induces the Wnt signalling pathway in 3T3-L1 adipocytes.

Authors:  Wilco W M Fleuren; Margot M L Linssen; Erik J M Toonen; Gerard C M van der Zon; Bruno Guigas; Jacob de Vlieg; Wim H A Dokter; D Margriet Ouwens; Wynand Alkema
Journal:  Arch Physiol Biochem       Date:  2013-03-19       Impact factor: 4.076

7.  The acute effects on duodenal gene expression in healthy men following consumption of a low-fat meal enriched with theobromine or fat.

Authors:  Lotte Smolders; Ronald P Mensink; Mark V Boekschoten; Rogier J J de Ridder; Jogchum Plat
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.